Type 2 diabetes mellitus (T2DM) is anticipated to have the highest share, which is 44.2% of the market in 2026
The core ingredients in the formula are backed by 624 clinical studies covering 44,692 participants
Interestingly, in the remission state, increased levels of Faecalibacterium and Eubacterium rectale were observed (Jiang et al., 2018)
Of these isomers, the most studied and bioavailable isomers are cis -9, trans -11 (abbreviated c9,t11) CLA (80%-90% of the total CLA isomers) and trans -10, cis -12 (abbreviated t10,c12) CLA (3%-5% of the total CLA isomers) within the naturally occurring forms
Provider review is included
This treatment is non-surgical, and no recovery time is required, allowing you to return to your daily routine after a quick treatment